Literature DB >> 7597040

T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease.

R Gold1, G Giegerich, H P Hartung, K V Toyka.   

Abstract

Predominant usage of V beta 8.2 gene segments, encoding a T-cell receptor (TCR) beta chain variable region, has been reported for pathogenic Lewis rat T cells reactive to myelin basic protein (MBP). However, up to 75% of the alpha/beta T cells in a panel of MBP-specific T-cell lines did not display TCR V beta 8.2, V beta 8.5, V beta 10, or V beta 16 elements. To further investigate TCR usage, we sorted the T-cell lines for V beta 8.2- and V beta 10-positive T cells or depleted the lines of cells with these TCRs. V beta 8.2-positive T cells and one of the depleted T-cell lines strongly reacted against the MBP peptide MBP-(68-88). The depleted T-cell line caused marked experimental autoimmune encephalomyelitis (EAE) even in Lewis rats in which endogenous V beta 8.2-positive T cells had been eliminated by neonatal treatment with anti-V beta 8.2 monoclonal antibodies. T-cell hybridomas generated from this line predominantly used V beta 3 TCR genes coexpressed with TCR V alpha 2 transcripts, which were also used by V beta 8.2-positive T cells. Furthermore, V beta 10-positive T cells reactive to MBP-(44-67) were encephalitogenic when injected immediately after positive selection. After induction of EAE by sorted V beta 8.2- or V beta 10-positive T-cell lines, immunocytochemical analysis of the spinal cord tissue showed a predominance of the injected TCR or of nontypable alpha/beta T cells after injection of the depleted line. Our results demonstrate heterogeneity of TCR beta-chain usage even for a single autoantigen in an inbred strain. Moreover, V beta 8.2-positive T cells are not essential for the induction and progression of adoptive-transfer EAE.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7597040      PMCID: PMC41599          DOI: 10.1073/pnas.92.13.5850

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Where, when, and how to detect biased expression of disease-relevant V beta genes in rats with experimental autoimmune encephalomyelitis.

Authors:  H Offner; A C Buenafe; M Vainiene; B Celnik; A D Weinberg; D P Gold; G Hashim; A A Vandenbark
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

2.  Novel Tcr Tcra-V and -J transcripts expressed in rat myelin-specific T-cell lines.

Authors:  A E Hinkkanen; J Määttä; Y F Qin; C Linington; A Salmi; H Wekerle
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  Spinal cord microglia in experimental allergic neuritis. Evidence for fast and remote activation.

Authors:  J Gehrmann; R Gold; C Linington; J Lannes-Vieira; H Wekerle; G W Kreutzberg
Journal:  Lab Invest       Date:  1992-07       Impact factor: 5.662

4.  Experimental allergic encephalomyelitis in susceptible and resistant strains of mice after adoptive transfer of T cells activated by antibodies to the T cell receptor complex.

Authors:  M L Zhao; J Q Xia; R B Fritz
Journal:  J Neuroimmunol       Date:  1992-09       Impact factor: 3.478

5.  Preferential distribution of V beta 8.2-positive T cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis.

Authors:  M Tsuchida; Y Matsumoto; H Hirahara; H Hanawa; K Tomiyama; T Abo
Journal:  Eur J Immunol       Date:  1993-10       Impact factor: 5.532

6.  Structure and diversity of rat T cell receptor alpha-chain genes.

Authors:  H Shirwan; M Ohanjanian; G Burcham; L Makowka; D V Cramer
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

7.  Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. I. T cell receptor peptide regulation of T cell clones expressing cross-reactive V beta genes.

Authors:  H Offner; M Vainiene; D P Gold; B Celnik; R Wang; G A Hashim; A A Vandenbark
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

8.  Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. II. Biased T cell receptor V beta expression predominates in spinal cord infiltrating T cells.

Authors:  D P Gold; M Vainiene; B Celnik; S Wiley; C Gibbs; G A Hashim; A A Vandenbark; H Offner
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

9.  Selective and nonselective stages in homing of T lymphocytes to the central nervous system during experimental allergic encephalomyelitis.

Authors:  N Karin; F Szafer; D Mitchell; D P Gold; L Steinman
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

10.  Diverse T cell receptor beta chain usage by rat encephalitogenic T cells reactive to residues 68-88 of myelin basic protein.

Authors:  D Sun; J Le; C Coleclough
Journal:  Eur J Immunol       Date:  1993-02       Impact factor: 5.532

View more
  7 in total

1.  Mild experimental autoimmune encephalitis as a tool to induce blood-brain barrier dysfunction.

Authors:  Michael K Boettger; Andreas Weishaupt; Christian Geis; Klaus V Toyka; Claudia Sommer
Journal:  J Neural Transm (Vienna)       Date:  2009-11-28       Impact factor: 3.575

Review 2.  Nanoparticle transport across the blood brain barrier.

Authors:  Andreas M Grabrucker; Barbara Ruozi; Daniela Belletti; Francesca Pederzoli; Flavio Forni; Maria Angela Vandelli; Giovanni Tosi
Journal:  Tissue Barriers       Date:  2016-02-25

Review 3.  Immunological self/nonself discrimination: integration of self vs nonself during cognate T cell interactions with antigen-presenting cells.

Authors:  M D Mannie
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

4.  Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis.

Authors:  Simone Wüst; Denise Tischner; Michael John; Jan P Tuckermann; Christiane Menzfeld; Uwe-Karsten Hanisch; Jens van den Brandt; Fred Lühder; Holger M Reichardt
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

5.  The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis.

Authors:  F X Weilbach; A Chan; K V Toyka; R Gold
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

Review 6.  T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms.

Authors:  R Gold; H P Hartung; H Lassmann
Journal:  Trends Neurosci       Date:  1997-09       Impact factor: 13.837

7.  Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.

Authors:  Niklas Beyersdorf; Stefanie Gaupp; Karen Balbach; Jens Schmidt; Klaus V Toyka; Chia-Huey Lin; Thomas Hanke; Thomas Hünig; Thomas Kerkau; Ralf Gold
Journal:  J Exp Med       Date:  2005-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.